BridgeMD
New treatment option for Mandibular Deficiency
Official title Mandibular Reconstruction With Axially Vascularised Bone Substitutes
ClinicalTrials.gov ID: NCT04001842
What this study is testing
- What it's testing
- Mandibular reconstruction is necessary following trauma, tumour resections and extensive infections resulting in severe defects of the mandibular arch. For reconstructing large and recurrent defects, the vascularized free flaps are currently regarded as the gold standard.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patients requiring mandibular reconstruction for further dental rehabilitation
- Mandibular defect (marginal/segmental) equals or more than 6 cm in largest dimension
- Middle age adult (18-65 years)
- Radiologically and pathologically documented tumour free mandibular defect
You likely can't join if
- Extremes of age (\ 65 years)
- Associated uncontrolled chronic illness (Diabetes mellitus, Hypertension, Rheumatoid arthritis, collagen disease, Chronic obstructive pulmonary...
- Primary reconstruction of a mandibular defect after tumour excision
The study team makes the final eligibility decision.
Where it's taking place
- Alexandria, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Alexandria, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.